06:45 EST Merck (MRK) to acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, or $9.2B
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Merck close to deal to acquire Cidara Therapeutics, FT reports
- Merck call volume above normal and directionally bullish
- Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
- Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
- Merck initiated with an Outperform at Scotiabank